Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × Valacyclovir × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 94 Radiotherapy 54 Radiation 26 Bevacizumab 16 Magnetic Resonance Spectroscopy 12 Nivolumab 11 Surgical Procedures, Operative 8 Irinotecan 8 Cyclophosphamide 8 pembrolizumab 7 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Radiosurgery 7 O(6)-benzylguanine 7 Flucytosine 7 Chemotherapy, Adjuvant 7 poly ICLC 6 motexafin gadolinium 6 Carmustine 6 sargramostim 5 fludarabine 5 Radiotherapy, Conformal 5 Lomustine 5 Leukapheresis 5 Imatinib Mesylate 5 Hydroxyurea 5 Erlotinib Hydrochloride 5 Drug Therapy 5 vocimagene amiretrorepvec 4 Sorafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00751270 2023-08-25

BrTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡